BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12945203)

  • 1. [The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains].
    Kiseleva IV; Grigor'eva EP; Naĭkhin AN; Ivanova VV; Larionova NV; Donina SA; Litvinova OM; Aleksandrova GI; Rudenko LG
    Vopr Virusol; 2003; 48(4):26-9. PubMed ID: 12945203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Live cold-adapted influenza vaccine: state-of-the-art].
    Gendon IuZ
    Vopr Virusol; 2011; 56(1):4-17. PubMed ID: 21427948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Restriction analysis of genome composition of live influenza vaccine].
    Kiseleva IV; Larionova NV; Teley LC; Rudenko LG
    Vopr Virusol; 2011; 56(3):28-32. PubMed ID: 21786624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].
    Kiseleva IV; Klimov AI; Grigor'eva EP; Larionova NV; Aleksandrova GI; Rudenko LG
    Vopr Virusol; 2005; 50(2):14-8. PubMed ID: 15881391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
    Joseph T; McAuliffe J; Lu B; Vogel L; Swayne D; Jin H; Kemble G; Subbarao K
    Virology; 2008 Aug; 378(1):123-32. PubMed ID: 18585748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3].
    Desheva IuA; Smolonogina TA; Sergeeva MV; Rekstin AR; Swayne D; Klimov AI; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (1):31-6. PubMed ID: 19340965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA].
    Desheva YA; Smolonogina TA; Doroshenko EM; Rudenko LG
    Vopr Virusol; 2016; 61(1):16-20. PubMed ID: 27145595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
    Desheva IuA; Lu Kh; Rekstin AR; Kats DM; Rudenko LG; Klimov AI
    Vopr Virusol; 2007; 52(4):27-30. PubMed ID: 17722607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferrets.
    Chen Z; Santos C; Aspelund A; Gillim-Ross L; Jin H; Kemble G; Subbarao K
    J Virol; 2009 Jan; 83(1):65-72. PubMed ID: 18945773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
    Isakova-Sivak I; Korenkov D; Smolonogina T; Tretiak T; Donina S; Rekstin A; Naykhin A; Shcherbik S; Pearce N; Chen LM; Bousse T; Rudenko L
    Virology; 2017 Jan; 500():209-217. PubMed ID: 27829176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.
    Snyder MH; Betts RF; DeBorde D; Tierney EL; Clements ML; Herrington D; Sears SD; Dolin R; Maassab HF; Murphy BR
    J Virol; 1988 Feb; 62(2):488-95. PubMed ID: 3336068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells].
    Kiseleva IV; Isakova IN; Larionova NV; Oleĭnik ES; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):40-5. PubMed ID: 18283733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The selection of cold-adapted variants of the influenza viruses H1N1 and H3N2 and their antigenic and genetic characteristics].
    Podcherniaeva RIa; Döhner L; Medvedeva TE; Aleksandrova GI
    Vopr Virusol; 1991; 36(2):100-2. PubMed ID: 1882517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine.
    Ghendon YZ; Markushin SG; Akopova II; Koptiaeva IB; Nechaeva EA; Mazurkova LA; Radaeva IF; Kolokoltseva TD
    Vaccine; 2005 Sep; 23(38):4678-84. PubMed ID: 16026905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
    Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG
    Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
    Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses.
    Romanova JR; Tannock GA; Alexandrova GI
    Vaccine; 1997; 15(6-7):653-8. PubMed ID: 9178466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.